Detection of rViscumin in plasma samples by immuno-PCR

Biochemical and Biophysical Research Communications

Volumn 300, Issue 3, 2003, Pages 757-763

  Adler, Michael ^a   Langer, Martin ^b   Witthohn, Klaus ^b   Eck, Jürgen ^c   Blohm, Dietmar ^d   Niemeyer, Christof M ^e  

^a CHIMERA BIOTEC GMBH   (Germany)

^b VISCUM AG   (Germany)

^c BRAIN AG   (Germany)

^d UNIVERSITY OF BREMEN   (Germany)

^e TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Assay sensitivity; Competitor; ELISA; Immuno PCR; Pharmacokinetic studies

Indexed keywords

ANTINEOPLASTIC AGENT; DNA FRAGMENT; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; RECOMBINANT VISCUMIN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SELECTIVITY; MOUSE; NONHUMAN; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0037449930     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02912-1     Document Type: Article

References (18)

1. Schumacher U., Feldhaus S., Mengs U. Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice. Cancer Lett. 150(2):2000;171-175.
2. Schaffrath B., Mengs U., Schwarz T., Hilgers R.D., Beuth J., Mockel B., Lentzen H., Gerstmayer B. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice. Anticancer Res. 21(6A):2001;3981-3987.
3. Elsasser-Beile U., Ruhnau T., Freudenberg N., Wetterauer U., Mengs U. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model. Cancer. 91(5):2001;998-1004.
4. Eck J., Langer M., Mockel B., Baur A., Rothe M., Zinke H., Lentzen H. Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain. Eur. J. Biochem. 264(3):1999;775-784.
5. Eck J., Langer M., Mockel B., Witthohn K., Zinke H., Lentzen H. Characterization of recombinant and plant-derived mistletoe lectin and their B-chains. Eur. J. Biochem. 265(2):1999;788-797.
6. Endo Y., Tsurugi K., Franz H. The site of action of the A-chain of mistletoe lectin I on eukaryotic ribosomes. The RNA N-glycosidase activity of the protein. FEBS Lett. 231(2):1988;378-380.
7. Langer M., Mockel B., Eck J., Zinke H., Lentzen H. Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis. Biochem. Biophys. Res. Commun. 264(3):1999;944-948.
8. K. Witthohn, personal communication, 1999.
9. Sano T., Smith C.L., Cantor C.R. Immuno-PCR very sensitive antigen detection by means of specific antibody-DNA conjugates. Science. 258(5079):1992;120-122.
10. Niemeyer C.M., Adler M., Blohm D. High sensitivity detection of antigens using immuno-PCR. NUNC Tech. Note. 5(35):1999.
11. Niemeyer C.M., Adler M., Blohm D. Fluorometric polymerase chain reaction (PCR) enzyme-linked immunosorbent assay for quantification of immuno-PCR products in microplates. Anal. Biochem. 246(1):1997;140-145.
12. Niemeyer C.M. Hochsensitiver PCR-Nachweis von Proteinen (IPCR). BIOSPEKTRUM. 6:1999;486-490.
13. Crowther J.R. ELISA; Theory and Practice. Walker J.M. Methods in Molecular Biology. 1995;Humana Press, Totowa, NJ.
14. Niemeyer C.M., Adler M., Pignataro B., Lenhert S., Gao S., Chi L., Fuchs H., Blohm D. Self-assembly of DNA-streptavidin nanostructures and their use as reagents in immuno-PCR. Nucleic Acids Res. 27(23):1999;4553-4561.
15. C.M. Niemeyer, M. Adler, R. Wacker, Verfahren zum Nachweis von Substanzen in Flüssigkeiten, EP 01 114 562.0, CHIMERA BIOTEC GmbH, 2001.
16. Niemeyer C.M., Burger W., Hoedemakers R.M. Hybridization characteristics of biomolecular adaptors, covalent DNA-streptavidin conjugates. Bioconjug. Chem. 9(2):1998;168-175.
17. Orlando C., Pinzani P., Pazzagli M. Developments in quantitative PCR. Clin. Chem. Lab. Med. 36(5):1998;255-269.
18. Reischl U., Kochanowski B. Quantitative PCR. A survey of the present technology. Mol. Biotechnol. 3(1):1995;55-71.